3-(3-(2-aminopropan-2-yl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl)-N-cyclopropyl-5-fluoro-4-methylbenzamide

ID: ALA2087521

PubChem CID: 25060630

Max Phase: Preclinical

Molecular Formula: C20H22FN5O

Molecular Weight: 367.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccn2c(C(C)(C)N)nnc2c1

Standard InChI:  InChI=1S/C20H22FN5O/c1-11-15(8-13(9-16(11)21)18(27)23-14-4-5-14)12-6-7-26-17(10-12)24-25-19(26)20(2,3)22/h6-10,14H,4-5,22H2,1-3H3,(H,23,27)

Standard InChI Key:  OJAXNTGFVLEVJY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   15.3444  -16.8166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3432  -17.6440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0581  -18.0569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7745  -17.6435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7716  -16.8130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0563  -16.4039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4846  -16.3978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2006  -16.8076    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.4814  -15.5728    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.9135  -16.3924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7374  -16.3931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3222  -15.6802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6285  -18.0559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0579  -18.8819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3381  -19.2903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7648  -20.1171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7687  -19.2895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0484  -20.5282    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.3388  -20.1122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7239  -20.6586    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0535  -21.4122    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.8716  -21.3317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3049  -22.0285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6298  -16.4043    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.9160  -22.7560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1295  -22.0015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7125  -22.7375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2 13  1  0
  1  2  2  0
  3 14  1  0
 14 15  2  0
  5  7  1  0
  3  4  2  0
  7  8  1  0
 14 17  1  0
 15 19  1  0
 18 16  1  0
 16 17  2  0
 18 19  1  0
  7  9  2  0
  4  5  1  0
  8 10  1  0
 11 10  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 18  1  0
 12 11  1  0
 22 23  1  0
 10 12  1  0
  1 24  1  0
  2  3  1  0
 23 25  1  0
  5  6  2  0
 23 26  1  0
  6  1  1  0
 23 27  1  0
M  END

Associated Targets(Human)

MAPK13 Tchem MAP kinase p38 delta (2605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Blood (2950 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 367.43Molecular Weight (Monoisotopic): 367.1808AlogP: 2.93#Rotatable Bonds: 4
Polar Surface Area: 85.31Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.21CX LogP: 1.84CX LogD: 0.97
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.74Np Likeness Score: -1.31

References

1. Aiguadé J, Balagué C, Carranco I, Caturla F, Domínguez M, Eastwood P, Esteve C, González J, Lumeras W, Orellana A, Preciado S, Roca R, Vidal L, Vidal B..  (2012)  Novel triazolopyridylbenzamides as potent and selective p38α inhibitors.,  22  (10): [PMID:22521646] [10.1016/j.bmcl.2012.03.099]

Source